1.99mTc-HMPAO labelled WBC scan in experimental abscess by labelling autologous leukocu\ytes with in-house-synthesized HMPAO.
Dong Soo LEE ; Hyung Sik SHIN ; Curie AHN ; June Key CHUNG ; Myung Chul LEE ; Kang Won CHOI ; Chang Soon KOH ; Jae Min JUNG ; Eun Ju CHUNG
Korean Journal of Nuclear Medicine 1991;25(2):252-258
No abstract available.
Abscess*
;
Technetium Tc 99m Exametazime*
2.Different Uptake of Tc-99m ECD and Tc-99m HMPAO in the Normal Brains - Analysis by Statistical Parametric Mapping.
Euy Neyng KIM ; Yong An JUNG ; Hyung Sun SOHN ; Sung Hoon KIM ; Ie Ryung YOO ; Soo Kyo CHUNG
Korean Journal of Nuclear Medicine 2002;36(4):244-254
No abstract available.
Brain*
;
Technetium Tc 99m Exametazime*
3.Radiopharmaceutical factors in the prepartion of 99mTc-HMPAO imagesof the brain.
Mi Kyoung YEOM ; Sang Eun KIM ; Dong Soo LEE ; June Key CHUNG ; Myung Chul LEE ; Chang Soon KOH
Korean Journal of Nuclear Medicine 1991;25(1):117-121
No abstract available.
Brain*
;
Technetium Tc 99m Exametazime*
4.Radiopharmaceutical factors in the prepartion of 99mTc-HMPAO imagesof the brain.
Mi Kyoung YEOM ; Sang Eun KIM ; Dong Soo LEE ; June Key CHUNG ; Myung Chul LEE ; Chang Soon KOH
Korean Journal of Nuclear Medicine 1991;25(1):117-121
No abstract available.
Brain*
;
Technetium Tc 99m Exametazime*
5.99mTc-HMPAO WBC scan findings in pulmonary mucormycosis.
Chang Woon CHOI ; Sang Eun KIM ; Dong Soo LEE ; June Key CHUNG ; Myung Chul LEE ; Chang Soon KOH
Korean Journal of Nuclear Medicine 1991;25(2):296-297
No abstract available.
Mucormycosis*
;
Technetium Tc 99m Exametazime*
6.Optimization of Correction Factor for Linearization with Tc-99m HM PAO and Tc-99m ECD Brain SPECT.
Ihn Ho CHO ; Kohei HAYASHIDA ; Kyu Chang WON ; Hyoung Woo LEE ; Hiroshi WATABE ; Norihiko KUME ; Chikao UYAMA
Yeungnam University Journal of Medicine 1999;16(2):237-243
No abstract available.
Brain*
;
Technetium Tc 99m Exametazime
;
Tomography, Emission-Computed, Single-Photon*
7.99mTc-HMPAO regional cerebral blood flow SPECT in cerebral infarctsand ischemia.
Chi Moon HWANG ; Hye Yeon HAN ; Hee Sang KIM ; Kyung Hoi AHN
Journal of the Korean Academy of Rehabilitation Medicine 1992;16(3):265-271
No abstract available.
Ischemia*
;
Technetium Tc 99m Exametazime*
;
Tomography, Emission-Computed, Single-Photon*
8.Interictal and Provoked Interictal Tc-99m HMPAO SPECT in Focal Seizure; Correlation between Electroencephalography and SPECT in the Localization of the Epileptic Focus.
Won Yong LEE ; Kyung Han LEE ; Kyung Yoon EUR
Journal of the Korean Neurological Association 1993;11(3):348-355
The use of interictal Tc-99m HMPAO SPECT images for localizing epileptic foci is limited by low sensitivty and specificity, while the routine use of ictal images is impractical for obvious reasons. To find out the possibility to solve these problems. We tried to stimulate the epileptic foci by provocation technique.
Electroencephalography*
;
Seizures*
;
Sensitivity and Specificity
;
Technetium Tc 99m Exametazime*
;
Tomography, Emission-Computed, Single-Photon*
9.Prediction of Prognosis by Acetazolamide Brain Perfusion SPECT in Patients with Arteriovenous Malformation.
Sang Gyun BAE ; Jae Gon MOON ; Suk Mo LEE ; Han Gyu KIM ; Ha Yong YEOM ; Do Yoon HWANG
Korean Journal of Nuclear Medicine 2000;34(5):426-432
After surgical operation in patients with arteriovenous malformation (AVM), normal pressure perfusion breakthrough (NPPB) is one of the major complications. Brain perfusion SPECT with acetazolamide stress was known to be useful to evaluate the vascular reserve in several neurological and neurosurgical conditions. The authors performed acetazolamide brain perfusion SPECT in patients with AVM and compared the brain perfusion in the post-operative clinical courses. The acetazolamide brain perfusion SPECT was helpful in defining the prognosis of the patients with AVM. We describe 4 patients with AVM who had acetazolamide brain perfusion SPECT to examine the prognosis.
Acetazolamide*
;
Arteriovenous Malformations*
;
Brain*
;
Humans
;
Perfusion*
;
Prognosis*
;
Technetium Tc 99m Exametazime
;
Tomography, Emission-Computed, Single-Photon*
10.The Effect of Acetazolamide on Regional Cerebral Blood Flow in Patients with Ischemic Cerebrovascular Disease.
Sang Soo LEE ; Byoung Woo YOON ; Jae Kyu ROH ; Sang Bok LEE ; Ho Jin MYUNG ; Sang Eun KIM ; Myung Chul LEE
Journal of the Korean Neurological Association 1991;9(3):269-276
Acetazolamide, a selective-inhibitor of carbonic anhydrase. Has been shown to induce a rapid increase in cerebral blood flow by acidifying cerebral extracellular tluid in large doses. In order to assess the cerebral blood flow reserve, we investigated 14 patients with ischemic cerebrovascular disease using Tc-99m HMPAO SPECT before and after administration of acetazolamide.The patients after acetazolamide challenge showed variable pattems of vasodilating capacity which were classified as follows: group I. Accentuation of abnormal perfusion pattem; group II, no change in abnormal perfusion pattern: and group III. Blunting of abnormal perfusion pattern. Thirty-six percent of the patients studied qualified for group I. The p?tients in group I seem to have decreased vasodilating reserve in the area of cerebral ischemia. They are most likely to benefit by medical or surgical efforts to augment CBF delivery. Tc-99m HMPAO-SPECT with acetazolamide flow challenge may serve as an objective. Clinically accessible method for assessing blood flow reserve and as a kind of guide for the therapeutic strategy.
Acetazolamide*
;
Brain Ischemia
;
Carbonic Anhydrases
;
Humans
;
Perfusion
;
Technetium Tc 99m Exametazime
;
Tomography, Emission-Computed, Single-Photon
Result Analysis
Print
Save
E-mail